Blog - Page 4248 of 5383

ThursdayJul 31, 2008 6:15 am

Middle-of-the-Road is Best for Business and Stocks – Mid-Week Management Mantra

Business Management guru, Professor Michael Porter from the Harvard Business School, has postulated two types of approaches to competition: differentiation and cost leadership. Most corporations follow one of these two alternatives. The thinking has also permeated the world of stock investors. Niche players in luxury segments and generic market leaders are behind some top stocks. Such a black-and-white approach to business management and stock investing may be outmoded now. Segments have begun to overlap. The most demanding customers demand both the prestige of sporting brands, and the economies of plain-Jane generics. Circumstances also force customers to move vertically: the wealthy…

ThursdayJul 31, 2008 6:12 am

Buckeye Technologies Inc. (BKI) is Getting Enough Fiber

As part of the Paper and Paper Products industry, Buckeye Technologies Inc. (BKI) is a manufacturer and marketer of specialty fibers and nonwoven materials. Headquartered in Memphis, Tennessee, they trade on the New York Stock Exchange (NYSE). They are specialists in polymer chemistry and fiber science, making cellulose-based specialty products. Buckeye Technologies Inc. operates facilities in the United States, Germany, Canada, and Brazil. They sell their products globally to makers of consumer and industrial goods. Sixty-eight percent of their sales are outside the United States. However, they produce seventy-four percent of their products in the United States. The company offers…

ThursdayJul 31, 2008 6:10 am

Cereal + Plastic = Cereplast Inc. (CERP)

A simple mathematical equation has turned an idea into an innovative enterprise. Using renewable resources, Cereplast Inc. produces bio-based resins, which find use as substitutes for petroleum-based plastics. Headquartered in Hawthorne, California, and trading on the OTCBB, the company designs and manufactures proprietary starch-based renewable plastics. The starch used in these products comes from your typical morning cereal products such as corn, tapioca, and wheat. This starch also derives from potatoes. Bio-based resins offer manufacturers price stability from chaotic world petroleum prices. They also offer competitive costing compared to resins normally used. The process for making bio-based resins involves processing…

ThursdayJul 31, 2008 5:02 am

interCLICK, Inc. (ICLK.OB) is “One to Watch”

Headquartered in New York, New York, interCLICK, Inc. operates the interCLICK Network. They provide Internet advertising solutions for Internet publishers and advertisers in the United States. They are an online ad network that combines advanced behavioral targeting with site-by-site reporting. This allows advertisers to identify and track their desired audience. Michael Katz founded the company in 2004 with the help of some fraternity brothers from Syracuse University, along with a team of developers, which included his brother Andrew. Today, interCLICK maintains more than a hundred active advertiser relationships and approximately a thousand publisher relationships. The company became publicly traded public…

ThursdayJul 31, 2008 4:49 am

MedeFile International, Inc. (MDFI.OB) Reaches Agreement to Market Technology to Direct Technology Innovations’ National Client Base

MedeFile International, Inc. (MDFI.OB), a company using advanced technology to provide consumers with convenient and secure medical records management solutions, was pleased to announce this morning that it has reached an agreement with Direct Technology Innovations (DTI) to market its technology and services to DTI’s customer base. The MedeFile-Light subscription will be offered as a gift to customers who use DTI’s electronic payments systems. “As a recognized national leader in transaction technology, it is our belief that there is no more important personal transaction than what takes place between a patient and his or her doctor. MedeFile's innovative approach to…

ThursdayJul 31, 2008 4:29 am

RRsat Global Communications (RRST) Beats 2Q Estimates, Raises Guidance

RRsat Global Communications Network Ltd. (RRST), an Israeli provider of global content management and distribution services to television and radio broadcasters, announced second quarter financial results this morning. Revenues rose 30% to $19.1 million vs. analysts’ consensus of $18.5 million. Adjusted net income (non-GAAP) was $3.6 million, or 20 cents per share, an increase of 31% and 3 cents better than analysts’ estimates. Net income on a GAAP basis was $3.3 million, or 19 cents per share. Backlog of signed agreements continues to rise, reaching a record $174 million at quarter’s end. RRsat raised revenue guidance for the full year…

ThursdayJul 31, 2008 4:13 am

Dawson Geophysical Co. (DWSN) Reports Strong Q3 Results, Beats Earnings Estimates by 14 Cents

Dawson Geophysical Company (DWSN), a leading provider of U.S. onshore seismic data acquisition services to oil and natural gas exploration and development companies, announced strong third quarter financial results this morning. Revenues were $84.6 million, an increase of 23% over prior year sales. Net income increased 28% to $9.7 million, or $1.27 per share. Analysts surveyed expected Dawson to report earnings of $1.13 per share on $82.7 million in revenues. Fossil fuel prices near historical highs have Dawson’s clients engaged in frenzied domestic exploration activities, particularly those seeking natural gas shale plays like the Haynesville and Barnett. The company continues…

ThursdayJul 31, 2008 4:12 am

Lexicon Pharmaceuticals, Inc. (LXRX) Announces Positive Phase I Trial of LX1031 for Irritable Bowel Syndrome

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), a biopharmaceutical company that focuses on discovering and developing breakthrough treatments for various human disease, recently announced the successful completion of the company’s Phase 1 multiple-dose escalation study in normal volunteers with LX1031, its oral drug candidate for irritable bowel syndrome (IBS). The recently completed trial for LX13031 was a randomized, double-blind, ascending multiple-dose study in which all dose levels were well tolerated over 14 days and no dose limiting toxicities were observed. Based on the success of the Phase I trial, Lexicon Pharmaceuticals plans to progress the new drug candidate into Phase II studies…

ThursdayJul 31, 2008 4:10 am

Microtune, Inc. (TUNE) Reports Second Quarter Earnings – Expects Positive Outlook for the Third and Fourth Quarters

Microtune, Inc. (NASDAQ: TUNE), a silicon and subsystems company that designs and markets radio frequency (RF) solutions for the worldwide consumer electronics and automotive electronics markets, recently reported its financial results for the second quarter that ended June 30, 2008. Microtune’s net revenue for the second quarter totaled $26.6 million, a 7% year-over-year increase compared to net revenue of $24.8 million for the same period one year earlier. Non-GAAP net income per diluted share reached $0.06 for the second quarter versus $0.07 in the second quarter of 2007. Shares for Microtune traded higher earlier this week on the company’s strong…

WednesdayJul 30, 2008 4:31 pm

O2Micro International Limited (OIIM) Reports Better than Expected Q2 Results

O2Micro International Limited (OIIM), a leading developer of power management and security components for computers and consumer electronics, reported second quarter financial results today after the close. Revenues were $40.8 million, an increase of 6.8% from the prior year and 8.6% sequentially. GAAP net income, including the effect of $721,000 in stock-based compensation expense, was $4.4 million, or 12 cents per American Depositary Share (ADS), vs. analysts’ consensus estimate of 10 cents per ADS. Sterling Du, Chairman and CEO, commented, “During these challenging economic times, we are continuing to grow because O2Micro is bringing great new products to the market.”…

Site Search

Company Search